IP International Journal of Ocular Oncology and Oculoplasty (IJOOO) open access, peer-reviewed quarterly journal publishing since 2016 and is published under the Khyati Education and Research Foundation (KERF), is registered as a non-profit society (under the society registration act, 1860), Government of India with the vision of various accredited vocational courses in healthcare, education, paramedical, yoga, publication, teaching and research activity, with the aim of faster and better dissemination of knowledge, we will be publishing the article ‘Ahead of Print’ immediately on acceptance. In addition, the journal would allow free access (Open Access) to its contents, which is likely to attract more readers and citations to articles published in IJOOO.
Manuscripts must be prepared in accordance with “Uniform requirements for Manuscripts submitted to Biomedical Journals” as per guidelines by the International Committee of Medical Journals Editors (Updated December 2019). The uniform requirements and specific requirements of IJOOO are mentioned below. Before sending a manuscript contributors are requested to check for the author guidelines are available from the website of the journal (www.ijooo.org/info/author) or directly from (Innovative Pre-Publication Portal) manuscript submission website https://innovpub.org/journal/IJOOO
Aims and Scope
The aim and commitment of the journal are to publish a research-oriented manuscript address significant issues in all the subjects and areas of Ocular Oncology and Oculoplasty. Journal is committed itself to improve Education and Research on Blurred Vision, Cataract, Macular Degeneration, Glaucoma, Diabetic Retinopathy, Refractive Error, Internal Medicine, Pediatrics, General Surgery, Eye Pathology, Eye Diseases, Implement Laser Therapy, Dry Eyes, Strabismus (Misalignment/Deviation of Eyes), Proptosis (Bulged Eyes), Excessive Tearing (Tear Duct Obstruction), Uveitis, Eye Tumors, Lacrimal Apparatus, Eye Removal, Orbital Reconstruction, Blepharoplasty, Ptosis, Ectropion, Entropion, Epicanthoplasty, Tarsorrhaphy, etc.
Indexing and Abstracting Information
Index Copernicus, Google Scholar, Indian Science Abstracts, National Science Library, J- gate, ROAD, CrossRef, Microsoft Academic, Indian Citation Index (ICI).
Journal is committed to upholding the highest standards of ethical behavior at all stages of publication. We strictly adhere to the industry associations such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE), and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. Our specific policies regarding duplicate publication, conflict of interest, patient consent, etc., Please visit the editor guidelines
Self-plagiarism is the redundant reuse of your own work, “use another’s production without crediting the sources,” or “present as new and original an idea or product derived from an existing source.” The IJOOO also considers “self-plagiarism” as a form of plagiarism. An example of self-plagiarism would be when an author borrows from his or her own previously published work without the proper citation within the newly submitted manuscript. We provide iThenticate - Similarity Check software to our editor and reviewers as a part of our manuscript submission system.
Innovative Publication has a primary partnership with CLOCKSS Archive to provide long-term digital preservation.
CLOCKSS is a collaborative project between 14 leading publishers and 34 institutional libraries to provide a ‘dark archive’ that guarantees long-term preservation and access. It uses the LOCKS technology to archive all material from participating publishers.
Ahead of Print Policy
Articles published online under the “Ahead of Print” model are considered published and can be cited and quoted using DOI as the reference source. Innovative Publication has a policy that changes WILL NOT be made after the publication of an article unless an accepted procedure for making corrections to the scientific record is followed.
Open Access (OA) Publication and Creative Commons Licensing
IJOOO is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-
Open Access (OA) provides a sustainable funding model for scientific communications while ensuring the widest possible access to research. Wider audiences and new readers can now freely access research articles without the hassle of payment or institutional support, which may be required to cover the expensive subscription. Open Access allows readers to use articles and data in new ways, including practices like meta-analysis and text mining, which reveal trends in science that would not be obvious at the level of individual articles.
IP International Journal of Ocular Oncology and Oculoplasty is a self-financed open access journal, which is published in both online and print versions. Article publication charges levied to authors are the only source of income that is utilized in maintaining the administrative and the print cost. Also, the very least part of revenue comes from advertisements and subscriptions.
The APC is based on an adjusted scale, providing reduced rates for low- and middle-income countries on the publication charges. Operating expense including the cost of web presence, print version, pre-press preparations, and staff salaries is supported by above-mentioned resources.
KERF has outsourced all pre-publication, publication, and post-publication processes to the publisher, including APC management.
Please visit for APC details
Advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:
IJOOO does not endorse any product or service marked as an advertisement or promoted by a sponsor. Editorial content is not compromised by commercial or financial interests, or by any specific arrangements with advertising clients or sponsors. All advertisements and commercially sponsored publications are independent of editorial decisions. Advertisers will never be shown any manuscripts or other content prior to publication.
Once an advertisement has been deployed online, it will be withdrawn from the journal site at any time if the Editor(s)-in-Chief or Publisher requests its removal. All advertisements for drug-specific campaigns should encourage correct and rational use and must not be misleading.
Please send any complaints about advertising to email@example.com
IP Innovative Publication Private Limited
Innovative Publication is a part of IP Innovative Publication Private Limited, which is one of the reputed publishers in India, with more than 200+ books and 49+ journals in medical, dental, nursing, and pharmacy subjects in its portfolio. Our customers include professionals, institutions, and students of medicine, nursing, allied health, and pharmacy. Researchers, students, scholars, clinicians, and other healthcare professionals access Innovative journals from around the globe to educate themselves about new and innovative discoveries and to improve patient care.
Innovative was founded in April 2011 and has become a well-respected medical publisher in India that fully supports many of the popular open access models through its peer-review management system. The innovative Open Access policy has resulted in more than five thousand articles being downloaded daily from its wide spectrum of journals.
Innovative has proven itself a leading publisher in India and has now established its global presence in more than 20 countries worldwide. From humble beginnings, it has grown into a publishing company with annual revenue of 2.50 crore rupees in the last financial year (2020-2021).
Print and Online Scholarly Publisher, Peer-review system, Specialized in Medical, Dental, Nursing, and Pharmacy books and Journals as an Open Access (OA) Publisher.